83 related articles for article (PubMed ID: 9112655)
1. Characterization of dysfunctional protein S-Tokushima (K155-->E) in relation to the molecular interactions required for the regulation of blood coagulation.
Hayashi T; Nishioka J; Suzuki K
Pol J Pharmacol; 1996; 48(2):221-3. PubMed ID: 9112655
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of the dysfunction of protein S(Tokushima) (Lys155-->Glu) for the regulation of the blood coagulation system.
Hayashi T; Nishioka J; Suzuki K
Biochim Biophys Acta; 1995 Dec; 1272(3):159-67. PubMed ID: 8541347
[TBL] [Abstract][Full Text] [Related]
3. The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S.
van Wijnen M; Stam JG; van't Veer C; Meijers JC; Reitsma PH; Bertina RM; Bouma BN
Thromb Haemost; 1996 Sep; 76(3):397-403. PubMed ID: 8883277
[TBL] [Abstract][Full Text] [Related]
4. Synergistic cofactor function of factor V and protein S to activated protein C in the inactivation of the factor VIIIa - factor IXa complex -- species specific interactions of components of the protein C anticoagulant system.
Shen L; He X; Dahlbäck B
Thromb Haemost; 1997 Sep; 78(3):1030-6. PubMed ID: 9308749
[TBL] [Abstract][Full Text] [Related]
5. Regulation of prothrombinase activity by protein S.
van 't Veer C; Butenas S; Golden NJ; Mann KG
Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
[TBL] [Abstract][Full Text] [Related]
6. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
[TBL] [Abstract][Full Text] [Related]
7. Membrane binding and anticoagulant properties of protein S natural variants.
Baroni M; Pavani G; Marescotti D; Kaabache T; Borgel D; Gandrille S; Marchetti G; Legnani C; D'Angelo A; Pinotti M; Bernardi F
Thromb Res; 2010 Feb; 125(2):e33-9. PubMed ID: 19878975
[TBL] [Abstract][Full Text] [Related]
8. C4b-binding protein inhibits the factor V-dependent but not the factor V-independent cofactor activity of protein S in the activated protein C-mediated inactivation of factor VIIIa.
van de Poel RH; Meijers JC; Bouma BN
Thromb Haemost; 2001 May; 85(5):761-5. PubMed ID: 11372664
[TBL] [Abstract][Full Text] [Related]
9. Studies of the interaction between human protein S and human C4b-binding protein using deletion variants of recombinant human protein S.
Chang GT; Maas BH; Ploos van Amstel HK; Reitsma PH; Bertina RM; Bouma BN
Thromb Haemost; 1994 Apr; 71(4):461-7. PubMed ID: 8052964
[TBL] [Abstract][Full Text] [Related]
10. EGF-like module pair 3-4 in vitamin K-dependent protein S: modulation of calcium affinity of module 4 by module 3, and interaction with factor X.
Stenberg Y; Muranyi A; Steen C; Thulin E; Drakenberg T; Stenflo J
J Mol Biol; 1999 Oct; 293(3):653-65. PubMed ID: 10543957
[TBL] [Abstract][Full Text] [Related]
11. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
Evenäs P; García de Frutos P; Nicolaes GA; Dahlbäck B
Thromb Haemost; 2000 Aug; 84(2):271-7. PubMed ID: 10959700
[TBL] [Abstract][Full Text] [Related]
12. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
13. Cardiolipin enhances protein C pathway anticoagulant activity.
Fernández JA; Kojima K; Petäjä J; Hackeng TM; Griffin JH
Blood Cells Mol Dis; 2000 Apr; 26(2):115-23. PubMed ID: 10753602
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the anticoagulant activity of protein S by prothrombin.
Mitchell CA; Jane SM; Salem HH
J Clin Invest; 1988 Dec; 82(6):2142-7. PubMed ID: 2974048
[TBL] [Abstract][Full Text] [Related]
15. Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
Takeyama M; Nogami K; Saenko EL; Soeda T; Nishiya K; Ogiwara K; Yoshioka A; Shima M
Br J Haematol; 2008 Nov; 143(3):409-20. PubMed ID: 18759761
[TBL] [Abstract][Full Text] [Related]
16. Regulation of coagulation by protein S.
Castoldi E; Hackeng TM
Curr Opin Hematol; 2008 Sep; 15(5):529-36. PubMed ID: 18695379
[TBL] [Abstract][Full Text] [Related]
17. Coagulation factor V: an old star shines again.
Rosing J; Tans G
Thromb Haemost; 1997 Jul; 78(1):427-33. PubMed ID: 9198191
[TBL] [Abstract][Full Text] [Related]
18. The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activities.
Koenen RR; Gomes L; Tans G; Rosing J; Hackeng TM
Thromb Haemost; 2004 Jun; 91(6):1105-14. PubMed ID: 15175796
[TBL] [Abstract][Full Text] [Related]
19. Protein S Thr103Asn mutation associated with type II deficiency reproduced in vitro and functionally characterised.
Giri TK; García de Frutos P; Dahlbäck B
Thromb Haemost; 2000 Sep; 84(3):413-9. PubMed ID: 11019964
[TBL] [Abstract][Full Text] [Related]
20. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]